🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to test the safety and immunogenicity of MVA-B...
Status
Completed
Location
Multiple Locations
Start Date
2015-04
Trial ID
NCT02376400
Treatments Being Tested
The primary objective of the study is to evaluable the safety and to demons...
Status
Completed
Location
National Taiwan University Hospital
Start Date
2021-09-30
Trial ID
NCT05079633
Treatments Being Tested
This study is a randomized, simple-blinded comparative phase III clinical t...
Status
Completed
Location
Leoni factory (Governorate of Bizerte)
Start Date
2021-11-22
Trial ID
NCT05668065
Treatments Being Tested
This is a trial designed to assess the safety, reactogenicity and immunogen...
Status
Completed
Location
Emory Children's Center - Pediatric Infectious Diseases
Start Date
2018-08-21
Trial ID
NCT03589807
The purpose of this study is to test the safety and immunogenicity of MVA-B...
Status
Completed
Location
Multiple Locations
Start Date
2016-08
Trial ID
NCT02860650
Treatments Being Tested
This study is a Phase 1, randomized, open-label study of the prime-boost va...
Status
Unknown
Location
WRAIR, Clinical Trials Center
Start Date
2017-11-08
Trial ID
NCT03141138
Treatments Being Tested
The purpose of this study is to assess the safety, tolerability and immunog...
Status
Completed
Location
Malaria Clinical Trials Center at Seattle Biomedical Research Institute
Start Date
2011-06
Trial ID
NCT01397227
The purpose of this study is to test the safety and immunogenicity of MVA-B...
Status
Completed
Location
Multiple Locations
Start Date
2014-12-17
Trial ID
NCT02313077
Treatments Being Tested
SARS-CoV-2 is a highly transmissible and pathogenic coronavirus that emerge...
Status
Unknown
Location
Hospital de Clínicas de Porto Alegre
Start Date
2021-12-01
Trial ID
NCT05087368
This is an open-label evaluation of the safety, tolerability, immunogenicit...
Status
Completed
Location
University of Maryland-Baltimore, Center for Vaccine Development
Start Date
2016-01
Trial ID
NCT02601716
Treatments Being Tested